Dyne Therapeutics, Inc. (DYN)
NASDAQ·Healthcare·Biotechnology
$18.16
+0.64%
Mkt Cap $3.01B
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 2, 2026 | — | — | — | -$0.74 | -$0.76 | -2.70% | — | — |
| Q4 2025 Nov 5, 2025 | — | — | — | -$0.81 | -$0.76 | +6.17% | — | — |
| Q3 2025 Jul 28, 2025 | — | — | — | -$0.99 | -$0.97 | +2.02% | — | — |
| Q2 2025 May 8, 2025 | — | — | — | -$0.88 | -$1.05 | -19.32% | — | — |
| Q1 2025 Feb 27, 2025 | — | — | — | -$0.92 | -$0.88 | +4.35% | — | — |
| Q4 2024 Nov 12, 2024 | — | — | — | -$0.71 | -$0.96 | -35.21% | — | — |
| Q3 2024 Aug 12, 2024 | — | — | — | -$0.72 | -$0.70 | +2.78% | — | — |
| Q2 2024 May 2, 2024 | $1.67M | — | — | -$0.81 | -$0.81 | +0.00% | — | — |
| Q1 2024 Mar 5, 2024 | — | $3.79M | — | -$0.92 | -$1.09 | -18.48% | — | — |
| Q4 2023 Oct 30, 2023 | — | — | — | -$0.86 | -$0.99 | -15.12% | — | — |
| Q3 2023 Aug 3, 2023 | — | — | — | -$0.81 | -$1.08 | -33.33% | — | — |
| Q2 2023 May 11, 2023 | — | — | — | -$0.77 | -$0.78 | -1.30% | — | — |
| Q1 2023 Mar 2, 2023 | — | — | — | -$0.84 | -$0.74 | +11.90% | — | — |
| Q4 2022 Nov 3, 2022 | — | — | — | -$0.95 | -$0.80 | +15.79% | — | — |
| Q3 2022 Aug 4, 2022 | — | — | — | -$0.79 | -$1.01 | -27.85% | — | — |
| Q2 2022 May 2, 2022 | — | — | — | -$0.88 | -$0.69 | +21.59% | — | — |
| Q1 2022 Mar 10, 2022 | — | — | — | -$0.99 | -$1.00 | -1.01% | — | — |
| Q4 2021 Nov 4, 2021 | — | — | — | -$0.65 | -$0.83 | -27.69% | — | — |
| Q3 2021 Aug 5, 2021 | — | — | — | -$0.55 | -$0.58 | -5.45% | — | — |
| Q2 2021 May 6, 2021 | — | — | — | -$0.60 | -$0.50 | +16.67% | — | — |